Active Pharmaceutical Ingredient

Axitinib (CAS 319460-85-0) API Manufacturer & Supplier in India

Also known as: Inlyta (brand)

CAS: 319460-85-0 Tyrosine Kinase Inhibitor USP / BP / IP Bulk Supply Available
Axitinib API Manufacturer India | Mediocon Inc
Axitinib — Pharmaceutical Grade API

Product Overview

CAS No: 319460-85-0  |  MF: C₂₂H₁₈N₄OS  |  MW: 386.47 g/mol

Axitinib is a selective tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, and VEGFR-3. It is approved for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. Mediocon Inc supplies pharmaceutical-grade Axitinib meeting IP/BP/EP/USP standards.

Key Features

  • Selective VEGFR tyrosine kinase inhibitor
  • IP/BP/EP/USP compliant quality
  • Advanced renal cell carcinoma treatment
  • Suitable for oral tablet formulations

Applications

  • Renal cell carcinoma tablets
  • Oncology combination therapy
  • Targeted cancer treatment manufacturing
  • Clinical trial supplies

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameAxitinib
Also Known AsInlyta (brand)
CAS Number319460-85-0
Molecular FormulaC₂₂H₁₈N₄OS
Molecular Weight386.47 g/mol
CategoryOncology / Tyrosine Kinase Inhibitor
AppearanceWhite to Light Yellow Powder
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
Assay98.0% – 102.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Axitinib (CAS 319460-85-0) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Axitinib is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Stability data available (ICH Q1A guidelines) for regulatory submissions
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Axitinib API

What is the minimum order quantity for Axitinib API?
Mediocon Inc supplies Axitinib with a minimum order quantity of 1 kg (sample packs available for R&D). We accommodate both small R&D quantities and large commercial-scale orders. Contact our sales team at akshay@mediocon.com or +91 9309999757 for a tailored quote.
What pharmacopoeial grades of Axitinib does Mediocon supply?
We supply Axitinib conforming to IP / BP / EP / USP pharmacopoeial standards. Each batch is tested against full pharmacopoeial specifications and released with a Certificate of Analysis. Custom specifications can be accommodated for regulated markets.
What documentation is provided with Axitinib API?
Every shipment of Axitinib comes with: Certificate of Analysis (CoA), MSDS/SDS, Certificate of Origin (COO), and Drug Master File (DMF) support on request. We also provide GMP certification, ISO 9001:2015 compliance documentation, and full regulatory support for filings in USA (FDA), Europe (EMA), and other markets.
What is the lead time and shipping for Axitinib bulk orders?
Standard lead time for Axitinib is 2–4 weeks for standard orders; expedited shipments possible for urgent requirements. We ship to 40+ countries worldwide using approved pharmaceutical-grade packaging (25 kg HDPE drums / aluminium foil bags). All shipments include temperature-controlled logistics options where required by the product's storage conditions.
💬
Mediocon AI
Hello 👋 How can I help you today?